InsidersTradesSigma
Follow the Chemours Co share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Chemicals & Materials sector, Chemours Co has logged 214 insider filings. Market capitalisation: €2.2bn. The latest transaction was reported on 13 August 2026 (Acquisition). Among the most active insiders: Dignam Denise. Every trade is free.
214
Insider Decl.
n/a
Thresholds
€1m
12 ops.
Buy Volume
€145,472
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Chemours Co Buy (bullish), based on 9 analysts. Average price target: US$21.67.
44Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,534 of 29,064 companies
20.4
score / 100
Value29
Quality12
FCF yld2.2%
Earn yld-16%
EV/EBITDA20.3x
ROE·
Gross mgn16%
Net mgn-6.6%
Debt/EBITDA13.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 August 2026
Declarations214 total
3,378 shares@ US$14.95Common StockSEC:0001193125-26-349607:0
Canonical exit: 9 Nov 2026 (T+90)
1,935 shares@ US$15.53Common StockSEC:0001193125-26-349656:0
Canonical exit: 10 Nov 2026 (T+90)
2,426 shares@ US$15.24Common StockSEC:0001193125-26-349657:0
6,000 shares@ US$15.8250.0040% mcap100.0% of flowCommon StockSEC:0001193125-26-344632:0
Canonical exit: 5 Nov 2026 (T+90)
1,939.801 shares@ US$15.470.0013% mcap19.8% of flowCommon StockSEC:0001193125-26-344633:0
Canonical exit: 5 Nov 2026 (T+90)
1,934.231 shares@ US$15.510.0013% mcap100.0% of flowCommon StockSEC:0001193125-26-344634:0
Canonical exit: 5 Nov 2026 (T+90)
13,000 shares@ US$15.620.0086% mcap48.6% of flowCommon StockSEC:0001193125-26-344635:0
Canonical exit: 5 Nov 2026 (T+90)
3,087 shares@ US$15.110.0020% mcap19.3% of flowCommon StockSEC:0001193125-26-342338:0
3,350 shares@ US$14.940.0021% mcap20.7% of flowCommon StockSEC:0001193125-26-342481:0
Canonical exit: 4 Nov 2026 (T+90)
943 shares@ US$16.610.0006% mcap10.2% of flowCommon StockSEC:0001193125-26-332804:0
391 shares@ US$16.610.0002% mcap3.3% of flowCommon StockSEC:0001193125-26-332805:0
477 shares@ US$16.610.0003% mcap1.0% of flowCommon StockSEC:0001193125-26-332806:0
663 shares@ US$16.610.0004% mcap9.1% of flowCommon StockSEC:0001193125-26-332807:0
25,013 shares0Common StockSEC:0001193125-26-089503:0
3,359 shares@ US$18.2431.0% of flowCommon StockSEC:0001193125-26-089517:0
2,635 shares@ US$18.2434.2% of flowCommon StockSEC:0001193125-26-089513:0
22,220 shares@ US$18.2452.4% of flowCommon StockSEC:0001193125-26-089511:0
2,789 shares@ US$18.2444.9% of flowCommon StockSEC:0001193125-26-089431:0
3,232 shares@ US$18.2439.7% of flowCommon StockSEC:0001193125-26-089423:0
699 shares@ US$18.2430.0% of flowCommon StockSEC:0001193125-26-089403:0
1,781 shares0Common StockSEC:0001193125-26-077678:0
2,261 shares0Common StockSEC:0001193125-26-077676:0
1,294 shares@ US$15.4021.7% of flowCommon StockSEC:0000950170-25-112928:0
2,374 shares@ US$12.42100.0% of flowCommon StockSEC:0001062993-25-014470:0
4,068 shares@ US$12.0613.5% of flowCommon StockSEC:0001062993-25-014200:0
Canonical exit: 6 Nov 2025 (T+90)
25 of 214 declarations
关于 Chemours Co
科慕公司（股票代码：CC）是一家在美国纽约证券交易所（United States）上市的美国化工公司。该公司于2015年通过杜邦高性能化学品业务的剥离而成立，并作为一家独立的上市公司开始运营。其总部位于特拉华州威尔明顿，这使得科慕公司在美国主要工业中心拥有长期基础。如今，该公司将自己定位为全球高性能化学品供应商，拥有一系列知名品牌并在多个专业市场占据领先地位。([chemours.com](https://www.chemours.com/en/news-media-center/all-news/press-releases/2015/the-chemours-company-completes-spin-off-from-dupont-and-launches-as-an-independent-publicly-traded-c?utm_source=openai)) 科慕公司围绕三个核心业务部门组织：热能与专业解决方案（TSS）、钛白科技（TT）和先进高性能材料（APM）。TSS部门包括Opteon™品牌下的制冷剂和热管理解决方案，服务于空调、工业制冷、数据中心以及更广泛的能源转型应用。TT部门主要围绕二氧化钛，通过Ti-Pure™品牌进行销售，这是油漆、涂料、塑料和纸张的关键投入。APM部门涵盖高性能材料，包括Teflon™、Viton™和Nafion™等传统品牌，其终端市场涵盖汽车、电子、工业加工、医疗设备和能源。这一产品组合使科慕公司既有周期性工业敞口，也有更具防御性的特种化学品特许经营权。([chemours.com](https://www.chemours.com/en/about-chemours)) 从竞争角度看，科慕公司更应被视为一个特种化学品平台，而非纯粹的大宗商品生产商。其价值主张建立在应用专业知识、以客户为主导的产品开发以及具有强大市场认可度的可信品牌之上。公司强调其全球覆盖范围和广泛的制造足迹，这支持了供应可靠性和客户邻近性。2025年，业绩表现依然不均衡：TSS部门在Opteon™日益普及的推动下继续保持强劲势头，而TT和APM部门则在几个周期性敏感的终端市场面临需求疲软。一个值得关注的商业亮点是，2025年8月，三星电子对科慕公司的两相浸没式冷却液Opteon™进行了认证，这突显了其先进冷却技术的重要性。与此同时，2025年第二季度业绩反映了与新泽西州和解相关的诉讼费用，这再次表明法律和环境责任仍然是投资考量的重要组成部分。([chemours.com](https://www.chemours.com/en/about-chemours)) 对于投资者而言，科慕公司结合了特种化学品的上行潜力、产品创新以及受监管驱动的制冷剂替代机会。但其也存在显著的风险：盈利能力受二氧化钛定价、工业需求周期以及持续的诉讼和环境问题的影响。([investors.chemours.com](https://investors.chemours.com/news-releases/news-release-details/chemours-company-reports-fourth-quarter-and-full-year-2025/?utm_source=openai))
